Clinical Trials Results - National Cancer Institute

Skip to content

National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov


	Clinical Trials Search Results

	Quick Links


	Director's Corner Dictionary of Cancer Terms NCI Drug Dictionary Funding Opportunities NCI Publications Advisory Boards and Groups Science Serving People Español

Questions about cancer?


	1-800-4-CANCER

	LiveHelp® online chat

	NCI Highlights


	High Dose Chemotherapy Prolongs Survival for Leukemia Prostate Cancer Study Shows No Benefit for Selenium, Vitamin E Past Highlights



Results: 1 -5 of 5 Show results per page	View Search Criteria \| Help With Results


Sort By:	Version:	Format:


1.		PET and MRI in the Follow-up of Neoadjuvant Chemotherapy of Breast Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase III				Diagnostic				Closed				18 and over				Other				P020907 AOR02072, NCT00236275

Last Modified: 1/1/2009 First Published: 10/31/2007


2.		Phase I/II Study of Everolimus, Temozolomide, and 3D-Conformal Radiotherapy or Intensity-Modulated Radiotherapy Followed by Adjuvant Temozolomide With or Without Everolimus in Patients With Newly Diagnosed Glioblastoma

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase II, Phase I				Biomarker/Laboratory analysis, Treatment				Temporarily closed				18 and over				NCI				NCCTG-N057K N057K, NCT00553150


3.		Phase I, Open Label, Single Center Safety Study of [F-18]FLT

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase I				Diagnostic				Completed				18 and over				Other				D0008186 NCT00553748

Last Modified: 5/21/2008 First Published: 12/14/2007


4.		Phase I Study of Gold Sodium Thiomalate in Patients with Advanced Non-Small Cell Lung Cancer

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	Phase I				Biomarker/Laboratory analysis, Treatment				Temporarily closed				18 and over				NCI				MAYO-MC0622 MC0622, NCT00575393

Last Modified: 9/4/2008 First Published: 1/6/2006


5.		Pilot Study of the Safety and Accuracy of Fluorothymidine F 18 Positron Emission Tomography in Detecting Recurrent Disease in Patients With Gliomas

	Phase				Type				Status				Age				Sponsor				Protocol IDs

	No phase specified				Diagnostic				Completed				18 and over				NCI				UW-6230 6230, NCI-7223, 7223, NCT00276770

Select All on One Page

| | | | | | | |

A Service of the National Cancer Institute